# Atridia Pty Ltd. clinical trials: 36 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 36 trials with Atridia Pty Ltd. as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Atridia Pty Ltd.: 36 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/atridia-pty-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 36
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 36, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 14, 2026 | NCT07873671 | A Trial of RLX-2508-102 in Healthy Volunteers | Atridia Pty Ltd. | Early phase 1 | Not yet recruiting | Influenza | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873671) |
| July 7, 2026 | NCT07686484 | A Trial of HRS-3095 in Healthy Volunteers | Atridia Pty Ltd. | Early phase 1 | Active not recruiting | Chronic Spontaneous Urticaria | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07686484) |
| February 5, 2026 | NCT07390747 | A Trial of SHR-2173 in Healthy Volunteers | Atridia Pty Ltd. | Phase 1 | Completed | Immunology | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07390747) |
| January 22, 2026 | NCT07358377 | A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects... | Atridia Pty Ltd. | Phase 1 | Recruiting | Breast Cancer | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07358377) |
| November 20, 2025 | NCT07238647 | A Trial of HRS-5817 in Obese Participants | Atridia Pty Ltd. | Early phase 1 | Active not recruiting | Obesity | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07238647) |
| July 22, 2025 | NCT07078695 | A Trial of SHR-1139 in Healthy Volunteers | Atridia Pty Ltd. | Phase 1 | Active not recruiting | Psoriasis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07078695) |
| June 24, 2025 | NCT07033455 | A Trial of HRS-1893 in Healthy Volunteers | Atridia Pty Ltd. | Early phase 1 | Completed | Hypertrophic Cardiomyopathy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07033455) |
| February 17, 2025 | NCT06830850 | A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic... | Atridia Pty Ltd. | Phase 1 | Active not recruiting | Metastatic Castration Resistant Prostate Cancer | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06830850) |
| August 19, 2024 | NCT06560138 | A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic... | Atridia Pty Ltd. | Phase 1 | Withdrawn | HER2-expressing or HER2-mutated Locally or Metastatic Solid Tumors | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06560138) |
| August 19, 2024 | NCT06559007 | Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants | Atridia Pty Ltd. | Phase 1 | Completed | Prostate Cancer | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06559007) |
| July 25, 2024 | NCT06519981 | Phase 1 Study of HRS-9231 Safety and Pharmacokinetics in Healthy Caucasians | Atridia Pty Ltd. | Early phase 1 | Completed | MRI | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06519981) |
| November 2, 2023 | NCT06114745 | A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease | Atridia Pty Ltd. | Phase 1 | Completed | Alzheimer's Disease (AD) | 2 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06114745) |
| December 6, 2022 | NCT05638347 | A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. | Atridia Pty Ltd. | Phase 1 | Completed | Inflammatory Bowel Disease | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05638347) |
| October 26, 2022 | NCT05594875 | A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors | Atridia Pty Ltd. | Phase 1 | Completed | Advanced Solid Tumor | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05594875) |
| October 19, 2021 | NCT05082545 | Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors | Atridia Pty Ltd. | Phase 1 | Completed | Advanced Malignant Tumors | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05082545) |
| April 22, 2021 | NCT04855591 | A Trial of SHR-1703 in Healthy Subjects | Atridia Pty Ltd. | Phase 1 | Terminated | Asthma | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04855591) |
| April 2, 2021 | NCT04829305 | A Trial of SHR2285 in Healthy Subjects | Atridia Pty Ltd. | Phase 1 | Completed | Healthy Volunteers | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04829305) |
| March 16, 2021 | NCT04800263 | A Trial of SHR-1905 in Healthy Subjects | Atridia Pty Ltd. | Phase 1 | Completed | Asthma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04800263) |
| February 9, 2021 | NCT04745104 | A Trial of SHR-1707 in Healthy Young Adult and Elderly Subjects | Atridia Pty Ltd. | Phase 1 | Completed | Alzheimer Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04745104) |
| January 8, 2021 | NCT04701216 | A Trial of SHR8735 in Healthy Subjects | Atridia Pty Ltd. | Phase 1 | Completed | Healthy Volunteers | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04701216) |
| October 5, 2020 | NCT04573036 | A Trial of HRS4800 Tables in Healthy Male Subjects | Atridia Pty Ltd. | Phase 1 | Completed | Pain | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04573036) |
| September 23, 2020 | NCT04561128 | A Trial of SHR-1819 in Healthy Subjects | Atridia Pty Ltd. | Phase 1 | Completed | Healthy Volunteers | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04561128) |
| April 3, 2020 | NCT04333134 | A Trial of SHR3162 in Healthy Caucasian Volunteers | Atridia Pty Ltd. | Phase 1 | Completed | Healthy Volunteers | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04333134) |
| March 27, 2020 | NCT04324814 | A Trial of SHR-1701 in Subjects With Advanced Solid Tumors | Atridia Pty Ltd. | Phase 1 | Completed | Advanced Solid Tumor | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04324814) |
| March 10, 2020 | NCT04301804 | A Trial of SHR6390 in Healthy Caucasian Volunteers | Atridia Pty Ltd. | Phase 1 | Completed | Healthy Volunteers | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04301804) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 5 |
| Phase 1 | 31 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 28 |
| Active not recruiting | 4 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Neoplasms | 3 |
| Gout | 2 |
| Psoriasis | 2 |
| Asthma | 2 |
| Prostatic Neoplasms | 2 |
| Alzheimer Disease | 2 |
| Obesity | 1 |
| Acute Pain | 1 |
| Influenza, Human | 1 |
| Hyperuricemia | 1 |
| Chronic Urticaria | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
| Inflammatory Bowel Diseases | 1 |
| Breast Neoplasms | 1 |
| Hematologic Neoplasms | 1 |
| Pruritus | 1 |
| Pain | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Korean restaurants in the United States](https://specstream.ai/data/businesses/korean-restaurants/united-states)
- [Elementary schools in the United States](https://specstream.ai/data/businesses/elementary-schools/united-states)
- [B2B water treatment companies in the United States](https://specstream.ai/data/businesses/b2b-water-treatment-companies/united-states)
- [Tax law firms in the United States](https://specstream.ai/data/businesses/tax-law-firms/united-states)
- [Outpatient care facilities in the United States](https://specstream.ai/data/businesses/outpatient-care-facilities/united-states)
- [Hematology practices in the United States](https://specstream.ai/data/businesses/hematology-practices/united-states)
